Login Register Cart 0
Generic placeholder image

Current Medical Imaging

Editor-in-Chief

ISSN (Print): 1573-4056
ISSN (Online): 1875-6603

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Image-guided Cryotherapy for Musculoskeletal Tumors

Author(s): Rossella Scandiffio*, Elena Bozzi, Mohamed Ezeldin, Rodolfo Capanna, Matteo Ceccoli, Simone Colangeli, Davide M. Donati and Marco Colangeli

Volume 17, Issue 2, 2021

Published on: 25 August, 2020

Page: [166 - 178] Pages: 13

DOI: 10.2174/1573405616666200825162712

Price: $65

Abstract

Background: This article represents a review of the use of image-guided cryotherapy in the treatment of musculoskeletal tumor lesions. Cryotherapy is able to induce a lethal effect on cancer cells through direct and indirect mechanisms. In this manuscript, we combined our experience with that of other authors who have published on this topic in order to provide indications on when to use cryotherapy in musculoskeletal oncology.

Discussion: Image-Guided percutaneous cryotherapy is a therapeutic method now widely accepted in the treatment of patients with musculoskeletal tumors. It can be used both for palliative treatments of metastatic bone lesions and for the curative treatment of benign bone tumors, such as osteoid osteoma or osteoblastoma. In the treatment of bone metastases, cryotherapy plays a major role in alleviating or resolving disease-related pain, but it has also been demonstrated that it can have a role in local disease control. In recent years, the use of cryotherapy has also expanded for the treatment of both benign and malignant soft tissue tumors.

Conclusion: Percutaneous cryotherapy can be considered a safe and effective technique in the treatment of benign and malignant musculoskeletal tumors. Cryotherapy can be considered the first option in benign tumor lesions, such as osteoid osteoma, and a valid alternative to radiofrequency ablation. In the treatment of painful bone metastases, it must be considered secondarily to other standard treatments (radiotherapy, bisphosphonate therapy, and chemotherapy) when they are no longer effective in controlling the disease or when they cannot be repeated (for example, radiotherapy).

Keywords: Percutaneous cryotherapy, image-guided cryoablation, cryoprobe, musculoskeletal tumors, metastases, palliative care.

Graphical Abstract

[1]
Mahnken AH, König AM, Figiel JH. Current technique and application of percutaneous cryotherapy. RoFo Fortschr Geb Rontgenstr Nuklearmed 2018; 190(9): 836-46.
[http://dx.doi.org/10.1055/a-0598-5134] [PMID: 29665588]
[2]
Facchini G, Di Tullio P, Battaglia M, et al. Palliative embolization for metastases of the spine. Eur J Orthop Surg Traumatol 2016; 26(3): 247-52.
[http://dx.doi.org/10.1007/s00590-015-1726-y] [PMID: 26667933]
[3]
Bianchi G, Campanacci L, Ronchetti M, Donati D. Electrochemotherapy in the treatment of bone metastases: a phase ii trial. World J Surg 2016; 40(12): 3088-94.
[http://dx.doi.org/10.1007/s00268-016-3627-6] [PMID: 27443372]
[4]
Carrasco-Choque AL, Lara YF, Vivas-Bonilla I, Romero-Trejo C, Villa AR, Roldan-Valadez E. Perfusion volume correlates, percentage of involution, and clinical efficacy at diverse follow-up survey times after MR-guided focused ultrasound surgery in uterine fibroids: first report in a Mexican mestizo population. Eur Radiol 2015; 25(10): 2905-12.
[http://dx.doi.org/10.1007/s00330-015-3707-2] [PMID: 25809744]
[5]
Fiori R, Forcina M, Di Donna C, et al. Cryotherapy of acetabular osteoid osteoma under fluoroscopic guidance using the XperGuide System. Radiol Case Rep 2019; 14(8): 989-92.
[http://dx.doi.org/10.1016/j.radcr.2019.05.021] [PMID: 31198481]
[6]
Callstrom MR, Dupuy DE, Solomon SB, et al. Percutaneous image-guided cryoablation of painful metastases involving bone: multicenter trial. Cancer 2013; 119(5): 1033-41.
[http://dx.doi.org/10.1002/cncr.27793] [PMID: 23065947]
[7]
Rose PS, Morris JM. Cryosurgery/cryoablation in musculoskeletal neoplasms: history and state of the art. Curr Rev Musculoskelet Med 2015; 8(4): 353-60.
[http://dx.doi.org/10.1007/s12178-015-9307-6] [PMID: 26508037]
[8]
Cornelis F, Havez M, Lippa N, et al. Radiologically guided percutaneous cryotherapy for soft tissue tumours: A promising treatment. Diagn Interv Imaging 2013; 94(4): 364-70.
[http://dx.doi.org/10.1016/j.diii.2013.02.001] [PMID: 23491212]
[9]
Kujak JL, Liu PT, Johnson GB, Callstrom MR. Early experience with percutaneous cryoablation of extra-abdominal desmoid tumors. Skeletal Radiol 2010; 39(2): 175-82.
[http://dx.doi.org/10.1007/s00256-009-0801-z] [PMID: 19768644]
[10]
Cornelis F, Neuville A, Labrèze C, et al. Percutaneous cryotherapy of vascular malformation: initial experience. Cardiovasc Intervent Radiol 2013; 36(3): 853-6.
[http://dx.doi.org/10.1007/s00270-012-0434-9] [PMID: 22722720]
[11]
Awad SMI. The story behind cryosurgery. J Surg Dermatol 2017; 3(2): 161-3.
[12]
Lim CT, Tan LB, Nathan SS. Prospective evaluation of argon gas probe delivery for cryotherapy of bone tumours. Ann Acad Med Singapore 2012; 41(8): 347-53.
[PMID: 23010812]
[13]
Marcove RC, Miller TR. The treatment of primary and metastatic localized bone tumors by cryosurgery. Surg Clin North Am 1969; 49(2): 421-30.
[http://dx.doi.org/10.1016/S0039-6109(16)38799-0] [PMID: 5774987]
[14]
Malawer MM, Bickels J, Meller I, Buch RG, Henshaw RM, Kollender Y. Cryosurgery in the treatment of giant cell tumor. A long-term followup study. Clin Orthop Relat Res 1999; (359): 176-88.
[http://dx.doi.org/10.1097/00003086-199902000-00019] [PMID: 10078141]
[15]
Chen C, Garlich J, Vincent K, Brien E. Postoperative complications with cryotherapy in bone tumors. J Bone Oncol 2017; 7: 13-7.
[http://dx.doi.org/10.1016/j.jbo.2017.04.002] [PMID: 28413772]
[16]
Cooper IS. Cryogenic surgery of the basal ganglia. JAMA 1962; 181: 600-4.
[http://dx.doi.org/10.1001/jama.1962.03050330030006] [PMID: 13881141]
[17]
Pritsch T, Bickels J, Wu CC, Squires HM, Malawer MM. The risk for fractures after curettage and cryosurgery around the knee. Clin Orthop Relat Res 2007; 458(458): 159-67.
[http://dx.doi.org/10.1097/BLO.0b013e318038fc3d] [PMID: 17290156]
[18]
McMenomy BP, Kurup AN, Johnson GB, et al. Percutaneous cryoablation of musculoskeletal oligometastatic disease for complete remission. J Vasc Interv Radiol 2013; 24(2): 207-13.
[http://dx.doi.org/10.1016/j.jvir.2012.10.019] [PMID: 23265724]
[19]
Colangeli S, Parchi P, Andreani L, et al. Cryotherapy efficacy and safety as local therapy in surgical treatment of musculoskeletal tumours. A retrospective case series of 143 patients. J Biol Regul Homeost Agents 2018; 32(6)(Suppl. 1): 65-70.
[PMID: 30644284]
[20]
Gage AA, Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology 1998; 37(3): 171-86.
[http://dx.doi.org/10.1006/cryo.1998.2115] [PMID: 9787063]
[21]
McCarty TM, Kuhn JA. Cryotherapy for liver tumors. Oncology (Williston Park) 1998; 12(7): 979-87.
[22]
Cooper SM, Dawber RP. The history of cryosurgery. J R Soc Med 2001; 94(4): 196-201.
[http://dx.doi.org/10.1177/014107680109400416] [PMID: 11317629]
[23]
Lal P, Thota PN. Cryotherapy in the management of premalignant and malignant conditions of the esophagus. World J Gastroenterol 2018; 24(43): 4862-9.
[http://dx.doi.org/10.3748/wjg.v24.i43.4862] [PMID: 30487696]
[24]
Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology 2002; 60(2): 40-9.
[http://dx.doi.org/10.1016/S0090-4295(02)01683-7] [PMID: 12206847]
[25]
Gage AA, Baust JM, Baust JG. Experimental cryosurgery investigations in vivo. Cryobiology 2009; 59(3): 229-43.
[http://dx.doi.org/10.1016/j.cryobiol.2009.10.001] [PMID: 19833119]
[26]
Cranwell WC, Sinclair R. Optimising cryosurgery technique. Aust Fam Physician 2017; 46(5): 270-4.
[PMID: 28472571]
[27]
Wen J, Duan Y, Zou Y, et al. Cryoablation induces necrosis and apoptosis in lung adenocarcinoma in mice. Technol Cancer Res Treat 2007; 6(6): 635-40.
[http://dx.doi.org/10.1177/153303460700600607] [PMID: 17994794]
[28]
Kuylenstierna R, Lundquist PG. Bone destruction by direct cryoapplication: a temperature study in rabbits. Cryobiology 1982; 19(3): 231-6.
[http://dx.doi.org/10.1016/0011-2240(82)90148-1] [PMID: 7105776]
[29]
Souna BS, Belot N, Duval H, Langlais F, Thomazeau H. No recurrences in selected patients after curettage with cryotherapy for grade I chondrosarcomas. Clin Orthop Relat Res 2010; 468(7): 1956-62.
[http://dx.doi.org/10.1007/s11999-009-1211-1] [PMID: 20054673]
[30]
Ahlmann ER, Menendez LR, Fedenko AN, Learch T. Influence of cryosurgery on treatment outcome of low-grade chondrosarcoma. Clin Orthop Relat Res 2006; 451(451): 201-7.
[http://dx.doi.org/10.1097/01.blo.0000229293.98850.5d] [PMID: 16788412]
[31]
Meller I, Weinbroum A, Bickels J, et al. Fifteen years of bone tumor cryosurgery: a single-center experience of 440 procedures and long-term follow-up. Eur J Surg Oncol 2008; 34(8): 921-7.
[http://dx.doi.org/10.1016/j.ejso.2007.11.001] [PMID: 18158228]
[32]
Yılmaz S, Özdoğan M, Cevener M, et al. Use of cryoablation beyond the prostate. Insights Imaging 2016; 7(2): 223-32.
[http://dx.doi.org/10.1007/s13244-015-0460-7] [PMID: 26762141]
[33]
Motamedi K, Levine BD, Bukata SV, Genshaft S. Percutaneous image-guided musculoskeletal tumor treatments. AJR Am J Roentgenol 2016; 207(3): 517-25.
[http://dx.doi.org/10.2214/AJR.16.16170] [PMID: 27224836]
[34]
Leng S, Christner JA, Carlson SK, et al. Radiation dose levels for interventional CT procedures. AJR Am J Roentgenol 2011; 197(1): W97-103.
[http://dx.doi.org/10.2214/AJR.10.5057] [PMID: 21701002]
[35]
Yang K, Ganguli S, DeLorenzo MC, Zheng H, Li X, Liu B. Procedure-specific CT Dose and Utilization Factors for CT-guided Interventional Procedures. Radiology 2018; 289(1): 150-7.
[http://dx.doi.org/10.1148/radiol.2018172945] [PMID: 30015583]
[36]
Overduin CG, Jenniskens SFM, Sedelaar JPM, Bomers JGR, Fütterer JJ. Percutaneous MR-guided focal cryoablation for recurrent prostate cancer following radiation therapy: Retrospective analysis of iceball margins and outcomes. Eur Radiol 2017; 27(11): 4828-36.
[http://dx.doi.org/10.1007/s00330-017-4833-9] [PMID: 28409355]
[37]
De Marini P, Cazzato RL, Garnon J, et al. Percutaneous MR-guided whole-gland prostate cancer cryoablation: safety considerations and oncologic results in 30 consecutive patients. Br J Radiol 2019; 92(1097): 20180965.
[http://dx.doi.org/10.1259/bjr.20180965] [PMID: 30845821]
[38]
Shimizu T, Sakuhara Y, Abo D, et al. Outcome of MR-guided percutaneous cryoablation for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2009; 16(6): 816-23.
[http://dx.doi.org/10.1007/s00534-009-0124-4] [PMID: 19466377]
[39]
Mogami T, Harada J, Kishimoto K, Sumida S. Percutaneous MR-guided cryoablation for malignancies, with a focus on renal cell carcinoma. Int J Clin Oncol 2007; 12(2): 79-84.
[http://dx.doi.org/10.1007/s10147-006-0654-6] [PMID: 17443274]
[40]
Ahmed M, Weinstein JL, Hussain J, Sarwar A, Anderson M, Dillon B. Percutaneous ultrasound-guided cryoablation for symptomatic plantar fibromas. Cardiovasc Intervent Radiol 2018; 41(2): 298-304.
[http://dx.doi.org/10.1007/s00270-017-1801-3] [PMID: 28975378]
[41]
Garnon J, Koch G, Caudrelier J, Tsoumakidou G, Cazzato RL, Gangi A. Expanding the borders: Image-guided procedures for the treatment of musculoskeletal tumors. Diagn Interv Imaging 2017; 98(9): 635-44.
[http://dx.doi.org/10.1016/j.diii.2017.07.009] [PMID: 28843590]
[42]
Tsoumakidou G, Too CW, Garnon J, Steib JP, Gangi A. Treatment of a spinal aneurysmal bone cyst using combined image-guided cryoablation and cementoplasty. Skeletal Radiol 2015; 44(2): 285-9.
[http://dx.doi.org/10.1007/s00256-014-1967-6] [PMID: 25091121]
[43]
Robinson D, Yassin M, Nevo Z. Cryotherapy of musculoskeletal tumors--from basic science to clinical results. Technol Cancer Res Treat 2004; 3(4): 371-5.
[http://dx.doi.org/10.1177/153303460400300407] [PMID: 15270588]
[44]
Koch G, Cazzato RL, Gilkison A, Caudrelier J, Garnon J, Gangi A. Percutaneous treatments of benign bone tumors. Semin Intervent Radiol 2018; 35(4): 324-32.
[http://dx.doi.org/10.1055/s-0038-1673640] [PMID: 30402015]
[45]
Sheng M, Wan L, Liu C, Liu C. Is cryosurgery a feasible local therapy for bone metastatic prostate cancer? Singapore Med J 2018; 59(11): 584-9.
[http://dx.doi.org/10.11622/smedj.2018119] [PMID: 30246213]
[46]
Agarwal MG, Nayak P. Management of skeletal metastases: An orthopaedic surgeon’s guide. Indian J Orthop 2015; 49(1): 83-100.
[http://dx.doi.org/10.4103/0019-5413.143915] [PMID: 25593359]
[47]
Mavrovi E, Vaz G, Thiesse P, Richioud B. Percutaneous cryoablation: A promising treatment for peripheral schwannoma. Diagn Interv Imaging 2016; 97(9): 923-5.
[http://dx.doi.org/10.1016/j.diii.2016.05.005] [PMID: 27316572]
[48]
Schmitz JJ, Schmit GD, Atwell TD, et al. Percutaneous cryoablation of extraabdominal desmoid tumors: A 10-year experience. AJR Am J Roentgenol 2016; 207(1): 190-5.
[http://dx.doi.org/10.2214/AJR.15.14391] [PMID: 27064168]
[49]
Xu J, Li J, Zhou X, et al. Cryotherapy for local recurrent dermatofibrosarcoma protuberans: experience in 19 patients. Cryobiology 2014; 68(1): 134-8.
[http://dx.doi.org/10.1016/j.cryobiol.2014.01.009] [PMID: 24463091]
[50]
Kutlubay Z, Küçüktaş M, Yardımcı G, Engin B, Serdaroğlu S. Evaluation of effectiveness of cryotherapy on the treatment of cutaneous Kaposi’s sarcoma. Dermatol Surg 2013; 39(10): 1502-6.
[http://dx.doi.org/10.1111/dsu.12285] [PMID: 23879208]
[51]
Saliken JC, McKinnon JG, Gray R. CT for monitoring cryotherapy. AJR Am J Roentgenol 1996; 166(4): 853-5.
[http://dx.doi.org/10.2214/ajr.166.4.8610562] [PMID: 8610562]
[52]
Thacker PG, Callstrom MR, Curry TB, et al. Palliation of painful metastatic disease involving bone with imaging-guided treatment: comparison of patients’ immediate response to radiofrequency ablation and cryoablation. AJR Am J Roentgenol 2011; 197(2): 510-5.
[http://dx.doi.org/10.2214/AJR.10.6029] [PMID: 21785102]
[53]
Kumasaka S, Miyazaki M, Tsushima Y. CT-guided percutaneous cryoablation of an aggressive osteoblastoma: A case report. J Vasc Interv Radiol 2015; 26(11): 1746-8.
[http://dx.doi.org/10.1016/j.jvir.2015.08.002] [PMID: 26505944]
[54]
Cazzato RL, Garnon J, Ramamurthy N, et al. Percutaneous image-guided cryoablation: current applications and results in the oncologic field. Med Oncol 2016; 33(12): 140.
[http://dx.doi.org/10.1007/s12032-016-0848-3] [PMID: 27837451]
[55]
Cazzato RL, Auloge P, Dalili D, et al. Percutaneous image-guided cryoablation of osteoblastoma. Ajr Am J Roentgenol 2019; 213(5): 1157-62.
[http://dx.doi.org/10.2214/AJR.19.21390] [PMID: 31310180]
[56]
Thibaut A, Bouhamama A, Boespflug A, et al. Percutaneous Cryotherapy for Treatment of Chondroblastoma: Early Experience. Cardiovasc intervent radiol 2019; 42(2): 304-7.
[http://dx.doi.org/10.1007/s00270-018-2085-y] [PMID: 30327928]
[57]
Tiefenboeck TM, Stockhammer V, Panotopoulos J, et al. Complete local tumor control after curettage of chondroblastoma-a retrospective analysis. Orthop Traumatol Surg Res 2016; 102(4): 473-8.
[http://dx.doi.org/10.1016/j.otsr.2016.01.025] [PMID: 27067177]
[58]
Zekry KM, Yamamoto N, Hayashi K, et al. Surgical treatment of chondroblastoma using extended intralesional curettage with phenol as a local adjuvant. J Orthop Surg (Hong Kong) 2019; 27(3): 2309499019861031.
[http://dx.doi.org/10.1177/2309499019861031] [PMID: 31315494]
[59]
Dabak N, Göçer H, Çıraklı A. Advantages of pressurized-spray cryosurgery in giant cell tumors of the bone. Balkan Med J 2016; 33(5): 496-503.
[http://dx.doi.org/10.5152/balkanmedj.2016.150473] [PMID: 27761276]
[60]
Wu PK, Chen CF, Wang JY, et al. Freezing nitrogen ethanol composite may be a viable approach for cryotherapy of human giant cell tumor of bone. Clin Orthop Relat Res 2017; 475(6): 1650-63.
[http://dx.doi.org/10.1007/s11999-017-5239-3] [PMID: 28197783]
[61]
Veth R, Schreuder B, van Beem H, Pruszczynski M, de Rooy J. Cryosurgery in aggressive, benign, and low-grade malignant bone tumours. Lancet Oncol 2005; 6(1): 25-34.
[http://dx.doi.org/10.1016/S1470-2045(05)70023-1] [PMID: 15629273]
[62]
Mohler DG, Chiu R, McCall DA, Avedian RS. Curettage and cryosurgery for low-grade cartilage tumors is associated with low recurrence and high function. Clin Orthop Relat Res 2010; 468(10): 2765-73.
[http://dx.doi.org/10.1007/s11999-010-1445-y] [PMID: 20574801]
[63]
Campanacci DA, Scoccianti G, Franchi A, et al. Surgical treatment of central grade 1 chondrosarcoma of the appendicular skeleton. J Orthop Traumatol 2013; 14(2): 101-7.
[http://dx.doi.org/10.1007/s10195-013-0230-6] [PMID: 23462877]
[64]
Skjeldal S, Lilleås F, Follerås G, et al. Real time MRI-guided excision and cryo-treatment of osteoid osteoma in os ischii-a case report. Acta Orthop Scand 2000; 71(6): 637-8.
[http://dx.doi.org/10.1080/000164700317362307] [PMID: 11145394]
[65]
Premat K, Clarençon F, Cormier É, et al. Long-term outcome of percutaneous alcohol embolization combined with percutaneous vertebroplasty in aggressive vertebral hemangiomas with epidural extension. Eur Radiol 2017; 27(7): 2860-7.
[http://dx.doi.org/10.1007/s00330-016-4664-0] [PMID: 27921158]
[66]
Cloran FJ, Pukenas BA, Loevner LA, Aquino C, Schuster J, Mohan S. Aggressive spinal haemangiomas: imaging correlates to clinical presentation with analysis of treatment algorithm and clinical outcomes. Br J Radiol 2015; 88(1055): 20140771.
[http://dx.doi.org/10.1259/bjr.20140771] [PMID: 26313498]
[67]
Müller DA, Capanna R. The surgical treatment of pelvic bone metastases. Adv Orthop 2015; 2015: 525363.
[http://dx.doi.org/10.1155/2015/525363] [PMID: 25810925]
[68]
Macedo F, Ladeira K, Pinho F, et al. Bone metastases: an overview. Oncol Rev 2017; 11(1): 321.
[PMID: 28584570]
[69]
Jacox A, Carr DB, Payne R. New clinical-practice guidelines for the management of pain in patients with cancer. N Engl J Med 1994; 330(9): 651-5.
[http://dx.doi.org/10.1056/NEJM199403033300926] [PMID: 7508094]
[70]
Marks RM, Sachar EJ. Undertreatment of medical inpatients with narcotic analgesics. Ann Intern Med 1973; 78(2): 173-81.
[http://dx.doi.org/10.7326/0003-4819-78-2-173] [PMID: 4683747]
[71]
Peteet J, Tay V, Cohen G, MacIntyre J. Pain characteristics and treatment in an outpatient cancer population. Cancer 1986; 57(6): 1259-65.
[http://dx.doi.org/10.1002/1097-0142(19860315)57:6<1259::AID-CNCR2820570633>3.0.CO;2-L] [PMID: 2417698]
[72]
Hellmann MD, Li BT, Chaft JE, Kris MG. Chemotherapy remains an essential element of personalized care for persons with lung cancers. Ann Oncol 2016; 27(10): 1829-35.
[http://dx.doi.org/10.1093/annonc/mdw271] [PMID: 27456296]
[73]
Roviello G, Francini E, Perrella A, et al. Five years of stable disease with maintenance therapy using bevacizumab and tamoxifen in a patient with metastatic breast cancer. Cancer Biol Ther 2015; 16(4): 493-7.
[http://dx.doi.org/10.1080/15384047.2015.1017692] [PMID: 25719413]
[74]
Unverzagt S, Moldenhauer I, Nothacker M, et al. Immunotherapy for metastatic renal cell carcinoma. Cochrane Database Syst Rev 2017; 5(5): CD011673.
[PMID: 28504837]
[75]
Himelstein AL, Foster JC, Khatcheressian JL, et al. Effect of longer-interval vs standard dosing of zoledronic acid on skeletal events in patients with bone metastases: a randomized clinical trial. JAMA 2017; 317(1): 48-58.
[http://dx.doi.org/10.1001/jama.2016.19425] [PMID: 28030702]
[76]
Landherr L, Nagykálnai T. Treatment of bone metastases: bisphosphonates and denosumab. Magy Onkol 2017; 61(2): 175-80.
[PMID: 28585620]
[77]
Body JJ, Gatta F, De Cock E, et al. An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: results from three European countries. Support Care Cancer 2017; 25(9): 2823-32.
[http://dx.doi.org/10.1007/s00520-017-3697-5] [PMID: 28429148]
[78]
Fairchild A. Palliative radiotherapy for bone metastases from lung cancer: Evidence-based medicine? World J Clin Oncol 2014; 5(5): 845-57.
[http://dx.doi.org/10.5306/wjco.v5.i5.845] [PMID: 25493222]
[79]
Kita K, Nakamura T, Yamanaka T, et al. Successful treatment with cryoablation in a patient with bone metastasis in the mid-shaft femur: a case report. OncoTargets Ther 2019; 12: 2949-53.
[http://dx.doi.org/10.2147/OTT.S195634] [PMID: 31114238]
[80]
Santiago FR, Del Mar Castellano García M, Montes JL, García MR, Fernández JM. Treatment of bone tumours by radiofrequency thermal ablation. Curr Rev Musculoskelet Med 2009; 2(1): 43-50.
[http://dx.doi.org/10.1007/s12178-008-9042-3] [PMID: 19468917]
[81]
Owen RJ. Embolization of musculoskeletal bone tumors. Semin Intervent Radiol 2010; 27(2): 111-23.
[http://dx.doi.org/10.1055/s-0030-1253510] [PMID: 21629401]
[82]
Bazzocchi A, Napoli A, Sacconi B, et al. MRI-guided focused ultrasound surgery in musculoskeletal diseases: the hot topics. Br J Radiol 2016; 89(1057): 20150358.
[http://dx.doi.org/10.1259/bjr.20150358] [PMID: 26607640]
[83]
Miklavčič D, Serša G, Brecelj E, et al. Electrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumors. Med Biol Eng Comput 2012; 50(12): 1213-25.
[http://dx.doi.org/10.1007/s11517-012-0991-8] [PMID: 23179413]
[84]
Nathan SS, Healey JH, Mellano D, et al. Survival in patients operated on for pathologic fracture: implications for end-of-life orthopedic care. J Clin Oncol 2005; 23(25): 6072-82.
[http://dx.doi.org/10.1200/JCO.2005.08.104] [PMID: 16135474]
[85]
Beals RK, Lawton GD, Snell WE. Prophylactic internal fixation of the femur in metastatic breast cancer. Cancer 1971; 28(5): 1350-4.
[http://dx.doi.org/10.1002/1097-0142(1971)28:5<1350::AID-CNCR2820280539>3.0.CO;2-6] [PMID: 5125680]
[86]
Filippiadis DK, Tutton S, Mazioti A, Kelekis A. Percutaneous image-guided ablation of bone and soft tissue tumours: a review of available techniques and protective measures. Insights Imaging 2014; 5(3): 339-46.
[http://dx.doi.org/10.1007/s13244-014-0332-6] [PMID: 24838839]
[87]
Callstrom MR, Kurup AN. Percutaneous ablation for bone and soft tissue metastases--why cryoablation? Skeletal Radiol 2009; 38(9): 835-9.
[http://dx.doi.org/10.1007/s00256-009-0736-4] [PMID: 19590871]
[88]
Laredo JD, Chiras J, Kemel S, Taihi L, Hamze B. Vertebroplasty and interventional radiology procedures for bone metastases. Joint Bone Spine 2018; 85(2): 191-9.
[http://dx.doi.org/10.1016/j.jbspin.2017.05.005] [PMID: 28499893]
[89]
Munk PL, Murphy KJ, Gangi A, Liu DM. Fire and ice: percutaneous ablative therapies and cement injection in management of metastatic disease of the spine. Semin Musculoskelet Radiol 2011; 15(2): 125-34.
[http://dx.doi.org/10.1055/s-0031-1275595] [PMID: 21500132]
[90]
Dodré E, Lefebvre G, Cockenpot E, Chastanet P, Cotten A. Interventional MSK procedures: the hip. Br J Radiol 2016; 89(1057): 20150408.
[http://dx.doi.org/10.1259/bjr.20150408] [PMID: 26317896]
[91]
Auloge P, Cazzato RL, Rousseau C, et al. Complications of percutaneous bone tumor cryoablation: a 10-year experience. Radiology 2019; 291(2): 521-8.
[http://dx.doi.org/10.1148/radiol.2019181262] [PMID: 30806603]
[92]
Mastier C, Gjorgjievska A, Thivolet A, et al. Musculoskeletal metastases management: the interventional radiologist’s toolbox. Semin intervent radiol 2018; 35(4): 281-9.
[http://dx.doi.org/10.1055/s-0038-1673420] [PMID: 30402011]
[93]
Susa M, Kikuta K, Nakayama R, et al. CT guided cryoablation for locally recurrent or metastatic bone and soft tissue tumor: initial experience. BMC Cancer 2016; 16(1): 798.
[http://dx.doi.org/10.1186/s12885-016-2852-6] [PMID: 27737652]
[94]
Tuncali K, Morrison PR, Winalski CS, et al. MRI-guided percutaneous cryotherapy for soft-tissue and bone metastases: initial experience. AJR Am J Roentgenol 2007; 189(1): 232-9.
[http://dx.doi.org/10.2214/AJR.06.0588] [PMID: 17579176]
[95]
Mankin HJ, Hornicek FJ, Springfield DS. Extra-abdominal desmoid tumors: a report of 234 cases. J Surg Oncol 2010; 102(5): 380-4.
[http://dx.doi.org/10.1002/jso.21433] [PMID: 19877160]
[96]
Masala S, Schillaci O, Bartolucci AD, Calabria F, Mammucari M, Simonetti G. Metabolic and clinical assessment of efficacy of cryoablation therapy on skeletal masses by 18F-FDG positron emission tomography/computed tomography (PET/CT) and visual analogue scale (VAS): initial experience. Skeletal Radiol 2011; 40(2): 159-65.
[http://dx.doi.org/10.1007/s00256-010-0960-y] [PMID: 20490789]
[97]
Romanato J, Menezes MR, Santos AO, Bezerra ROF, Lima MCL, Etchebehere E. 18F-FDG PET/CT performed immediately after percutaneous ablation to evaluate outcomes of the procedure: preliminary results. Radiol Bras 2019; 52(1): 24-32.
[http://dx.doi.org/10.1590/0100-3984.2018.0010] [PMID: 30804612]
[98]
Dupuy DE, Liu D, Hartfeil D, et al. Percutaneous radiofrequency ablation of painful osseous metastases: A multicenter American College of Radiology Imaging Network trial. Cancer 2010; 116(4): 989-97.
[http://dx.doi.org/10.1002/cncr.24837] [PMID: 20041484]
[99]
Goetz MP, Callstrom MR, Charboneau JW, et al. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: A multicenter study. J Clin Oncol 2004; 22(2): 300-6.
[http://dx.doi.org/10.1200/JCO.2004.03.097] [PMID: 14722039]
[100]
Nakatsuka A, Yamakado K, Maeda M, et al. Radiofrequency ablation combined with bone cement injection for the treatment of bone malignancies. J Vasc Interv Radiol 2004; 15(7): 707-12.
[http://dx.doi.org/10.1097/01.RVI.0000133507.40193.E4] [PMID: 15231884]
[101]
Nemcek AA. Complications of radiofrequency ablation of neoplasms. Semin Intervent Radiol 2006; 23(2): 177-87.
[http://dx.doi.org/10.1055/s-2006-941448] [PMID: 21326761]
[102]
Silverman SG, Tuncali K, Adams DF, et al. MR imaging-guided percutaneous cryotherapy of liver tumors: Initial experience. Radiology 2000; 217(3): 657-64.
[http://dx.doi.org/10.1148/radiology.217.3.r00dc40657] [PMID: 11110925]
[103]
Chapman WC, Debelak JP, Blackwell TS, et al. Hepatic cryoablation-induced acute lung injury: Pulmonary hemodynamic and permeability effects in a sheep model. Arch Surg 2000; 135(6): 667-72.
[http://dx.doi.org/10.1001/archsurg.135.6.667] [PMID: 10843362]
[104]
Haddad FF, Chapman WC, Wright JK, Blair TK, Pinson CW. Clinical experience with cryosurgery for advanced hepatobiliary tumors. J Surg Res 1998; 75(2): 103-8.
[http://dx.doi.org/10.1006/jsre.1998.5280] [PMID: 9655082]
[105]
Stewart GJ, Preketes A, Horton M, Ross WB, Morris DL. Hepatic cryotherapy: double-freeze cycles achieve greater hepatocellular injury in man. Cryobiology 1995; 32(3): 215-9.
[http://dx.doi.org/10.1006/cryo.1995.1021] [PMID: 7781325]
[106]
Bing F, Garnon J, Tsoumakidou G, Enescu I, Ramamurthy N, Gangi A. Imaging-guided percutaneous cryotherapy of bone and soft-tissue tumors: what is the impact on the muscles around the ablation site? Am J Roentgenol 2014; 202(6): 1361-5.
[http://dx.doi.org/10.2214/AJR.13.11430] [PMID: 24848836]
[107]
Ahmed O, Feinberg N, Lea WB. Interventional techniques for the ablation and augmentation of extraspinal lytic bone metastases. semin intervent radiol 2019; 36(3): 221-8.
[http://dx.doi.org/10.1055/s-0039-1693117] [PMID: 31435130]
[108]
Bertrand AS, Iannessi A, Natale R, et al. Focused ultrasound for the treatment of bone metastases: effectiveness and feasibility. J Ther Ultrasound 2018; 6: 8.
[http://dx.doi.org/10.1186/s40349-018-0117-3] [PMID: 30519467]
[109]
Holbert JA, Nguyen DT. Percutaneous radiofrequency ablation for painful spinal metastases resulting in resolution of epidural disease: a case report. Cureus 2018; 10(5): e2579.
[http://dx.doi.org/10.7759/cureus.2579] [PMID: 29984121]
[110]
Barile A, Arrigoni F, Bruno F, et al. Present role and future perspectives of interventional radiology in the treatment of painful bone lesions. Future Oncol 2018; 14(28): 2945-55.
[http://dx.doi.org/10.2217/fon-2017-0657] [PMID: 29693420]
[111]
Zarzour OA, Santiago FR, Serrano NO, Abdallah AH, El-Sharkawy MA, Mourad AF. CT-guided radiofrequency ablation in patients with aneurysmal bone cysts. Eur J Radiol 2018; 100: 116-23.
[http://dx.doi.org/10.1016/j.ejrad.2018.01.020] [PMID: 29496068]
[112]
Chiras J, Shotar E, Cormier E, Clarençon F. Interventional radiology in bone metastases. Eur J Cancer Care (Engl) 2017; 26(6): Epub ahead of Print.
[http://dx.doi.org/10.1111/ecc.12741] [PMID: 28873239]
[113]
Gatto L, Facchini G, Saponara M, et al. Successful selective arterial embolizations for bone metastases in renal cell carcinoma integrated with systemic therapies: A case report. Radiol Case Rep 2017; 12(4): 775-9.
[http://dx.doi.org/10.1016/j.radcr.2017.07.008] [PMID: 29484069]
[114]
Ma J, Tullius T, Van Ha TG. Update on preoperative embolization of bone metastases. Semin Intervent Radiol 2019; 36(3): 241-8.
[http://dx.doi.org/10.1055/s-0039-1693120] [PMID: 31435132]
[115]
Fritz J, Sonnow L, Morris CD. Adjuvant MRI-guided percutaneous cryoablation treatment for aneurysmal bone cyst. Skeletal Radiol 2019; 48(7): 1149-53.
[http://dx.doi.org/10.1007/s00256-018-3115-1] [PMID: 30523379]
[116]
Chen CF, Chu HC, Chen CM, et al. A safety comparative study between freezing nitrogen ethanol composite and liquid nitrogen for cryotherapy of musculoskeletal tumors. Cryobiology 2018; 83: 34-9.
[http://dx.doi.org/10.1016/j.cryobiol.2018.06.008] [PMID: 29953845]
[117]
Sangsin A, Murakami H, Shimizu T, Kato S, Tsuchiya H. Efficacy of vertebral cryoablation and immunotherapy in a patient with metastatic renal cell carcinoma: A case report. J Med Case Reports 2019; 13(1): 96.
[http://dx.doi.org/10.1186/s13256-019-2049-0] [PMID: 31005126]
[118]
Miyazaki M, Saito K, Yanagawa T, Chikuda H, Tsushima Y. Phase I clinical trial of percutaneous cryoablation for osteoid osteoma. Jpn J Radiol 2018; 36(11): 669-75.
[http://dx.doi.org/10.1007/s11604-018-0768-6] [PMID: 30109554]
[119]
Pipola V, Girolami M, Ghermandi R, Tedesco G, Evangelisti G, Gasbarrini A. Cryosurgery in the excision of a giant local recurrent sacral chordoma: a case report and literature review. Eur Spine J 2018; 27(12): 3059-63.
[http://dx.doi.org/10.1007/s00586-017-5438-3] [PMID: 29372428]
[120]
Santiago E, Pauly V, Brun G, Guenoun D, Champsaur P, Le Corroller T. Percutaneous cryoablation for the treatment of osteoid osteoma in the adult population. Eur Radiol 2018; 28(6): 2336-44.
[http://dx.doi.org/10.1007/s00330-017-5164-6] [PMID: 29294152]
[121]
Gardner CS, Ensor JE, Ahrar K, et al. Cryoablation of bone metastases from renal cell carcinoma for local tumor control. J Bone Joint Surg Am 2017; 99(22): 1916-26.
[http://dx.doi.org/10.2106/JBJS.16.01182] [PMID: 29135665]
[122]
Coupal TM, Pennycooke K, Mallinson PI, et al. The hopeless case? palliative cryoablation and cementoplasty procedures for palliation of large pelvic bone metastases. Pain Physician 2017; 20(7): E1053-61.
[PMID: 29149150]
[123]
Motta A, Caltabiano G, Palmucci S, Failla G, Basile A. Feasibility of percutaneous cryoablation of vertebral metastases under local anaesthesia in ASAIII patients. Eur J Radiol 2017; 95: 13-7.
[http://dx.doi.org/10.1016/j.ejrad.2017.07.011] [PMID: 28987657]
[124]
Rybak LD, Rosenthal DI, Wittig JC. Chondroblastoma: radiofrequency ablation--alternative to surgical resection in selected cases. Radiology 2009; 251(2): 599-604.
[http://dx.doi.org/10.1148/radiol.2512080500] [PMID: 19304917]
[125]
Gupta S, Gulia A, Kurisunkal V, Parikh M, Gupta S. Principles of management of extremity skeletal metastasis. Indian J Palliat Care 2019; 25(4): 580-6.
[http://dx.doi.org/10.4103/IJPC.IJPC_90_19] [PMID: 31673216]
[126]
Berrettoni BA, Carter JR. Mechanisms of cancer metastasis to bone. J Bone Joint Surg Am 1986; 68(2): 308-12.
[http://dx.doi.org/10.2106/00004623-198668020-00021] [PMID: 3753707]
[127]
Jones DH, Nakashima T, Sanchez OH, et al. Regulation of cancer cell migration and bone metastasis by RANKL. Nature 2006; 440(7084): 692-6.
[http://dx.doi.org/10.1038/nature04524] [PMID: 16572175]
[128]
Ogilvie CM, Fox EJ, Lackman RD. Current surgical management of bone metastases in the extremities and pelvis. Semin Oncol 2008; 35(2): 118-28.
[http://dx.doi.org/10.1053/j.seminoncol.2007.11.019] [PMID: 18396197]
[129]
Ahmad I, Ahmed MM, Ahsraf MF, et al. Pain management in metastatic bone disease: A literature review. Cureus 2018; 10(9): e3286.
[http://dx.doi.org/10.7759/cureus.3286] [PMID: 30443456]
[130]
Sundararajan SH, Calamita S, Girgis P, et al. Sequential interventional management of osseous neoplasms via embolization, cryoablation, and osteoplasty. J Oncol 2019; 2019: 5247837.
[http://dx.doi.org/10.1155/2019/5247837] [PMID: 31110519]
[131]
Di Staso M, Gravina GL, Zugaro L, et al. Treatment of solitary painful osseous metastases with radiotherapy, cryoablation or combined therapy: Propensity matching analysis in 175 patients. PLoS One 2015; 10(6): e0129021.
[http://dx.doi.org/10.1371/journal.pone.0129021] [PMID: 26103516]
[132]
Park JW, Kim HS, Yun JY, Han I. Neuropathic pain after sarcoma surgery: Prevalence and predisposing factors. Medicine (Baltimore) 2018; 97(21): e10852.
[http://dx.doi.org/10.1097/MD.0000000000010852] [PMID: 29794783]
[133]
Radtke C, Calliess T, Windhagen H, Vogt P. Skin and soft tissue complications after orthopedic interventions on tumors : Interdisciplinary management. Chirurg 2015; 86(3): 234-41.
[http://dx.doi.org/10.1007/s00104-014-2834-7] [PMID: 25801687]
[134]
Milbéo Y, Kantor G, Lagarde P, et al. Conservative and functional management for soft tissue sarcomas of the extremities: Role of radiotherapy. Cancer Radiother 2006; 10(6-7): 410-5.
[PMID: 16987679]
[135]
Littrup PJ, Bang HJ, Currier BP, et al. Soft-tissue cryoablation in diffuse locations: Feasibility and intermediate term outcomes. J Vasc Interv Radiol 2013; 24(12): 1817-25.
[http://dx.doi.org/10.1016/j.jvir.2013.06.025] [PMID: 24060437]
[136]
Levy MY, Sidana A, Chowdhury WH, et al. Cyclophosphamide unmasks an antimetastatic effect of local tumor cryoablation. J Pharmacol Exp Ther 2009; 330(2): 596-601.
[http://dx.doi.org/10.1124/jpet.109.152603] [PMID: 19407102]
[137]
Le Pivert PJ, Morrison DR, Haddad RS, et al. Percutaneous tumor ablation: microencapsulated echo-guided interstitial chemotherapy combined with cryosurgery increases necrosis in prostate cancer. Technol Cancer Res Treat 2009; 8(3): 207-16.
[http://dx.doi.org/10.1177/153303460900800305] [PMID: 19445538]
[138]
Li Z, Fu Y, Li Q, et al. Cryoablation plus chemotherapy in colorectal cancer patients with liver metastases. Tumour Biol 2014; 35(11): 10841-8.
[http://dx.doi.org/10.1007/s13277-014-2374-2] [PMID: 25081377]
[139]
Xu KC, Niu LZ, He WB, Hu YZ, Zuo JS. Percutaneous cryosurgery for the treatment of hepatic colorectal metastases. World J Gastroenterol 2008; 14(9): 1430-6.
[http://dx.doi.org/10.3748/wjg.14.1430] [PMID: 18322961]
[140]
Khanevich MD, Manikhas GM, Vashkurov SM, Kukanov MA, Khazov AV. Combination of vessel embolization and cryotherapy in surgical treatment of soft tissue sarcomas. Vestn Khir 2015; 174(4): 39-44.
[http://dx.doi.org/10.24884/0042-4625-2015-174-4-39-44] [PMID: 26601516]
[141]
den Brok MH, Sutmuller RP, Nierkens S, et al. Synergy between in situ cryoablation and TLR9 stimulation results in a highly effective in vivo dendritic cell vaccine. Cancer Res 2006; 66(14): 7285-92.
[http://dx.doi.org/10.1158/0008-5472.CAN-06-0206] [PMID: 16849578]
[142]
Redondo P, del Olmo J, López-Diaz de Cerio A, et al. Imiquimod enhances the systemic immunity attained by local cryosurgery destruction of melanoma lesions. J Invest Dermatol 2007; 127(7): 1673-80.
[http://dx.doi.org/10.1038/sj.jid.5700777] [PMID: 17380112]
[143]
Fuhrmann I, Probst U, Wiggermann P, Beyer L. Navigation systems for treatment planning and execution of percutaneous irreversible electroporation. Technol Cancer Res Treat 2018; 17: 1533033818791792.
[http://dx.doi.org/10.1177/1533033818791792] [PMID: 30071779]
[144]
Oliveira-Santos T, Klaeser B, Weitzel T, et al. A navigation system for percutaneous needle interventions based on PET/CT images: Design, workflow and error analysis of soft tissue and bone punctures. Comput Aided Surg 2011; 16(5): 203-19.
[http://dx.doi.org/10.3109/10929088.2011.597566] [PMID: 21787176]
[145]
Rivas R, Overbosch J, Kwee T, et al. Radiofrequency ablation of atypical cartilaginous tumors in long bones: A retrospective study. Int J Hyperthermia 2019; 36(1): 1189-95.
[http://dx.doi.org/10.1080/02656736.2019.1687943] [PMID: 31884842]
[146]
Auloge P, Cazzato RL, Koch G, et al. Percutaneous tumor ablation. Presse Med 2019; 48(10): 1146-55.
[http://dx.doi.org/10.1016/j.lpm.2019.10.011] [PMID: 31676219]
[147]
Fan QY, Zhou Y, Zhang M, et al. Microwave ablation of malignant extremity bone tumors. Springerplus 2016; 5(1): 1373.
[http://dx.doi.org/10.1186/s40064-016-3005-8] [PMID: 27606161]
[148]
Rinzler ES, Shivaram GM, Shaw DW, Monroe EJ, Koo KSH. Microwave ablation of osteoid osteoma: Initial experience and efficacy. Pediatr Radiol 2019; 49(4): 566-70.
[http://dx.doi.org/10.1007/s00247-018-4327-1] [PMID: 30617514]

Rights & Permissions Print Cite
Article Metrics
44
© 2024 Bentham Science Publishers | Privacy Policy